Avadel Pharmaceuticals (AVDL) Long-Term Investments: 2010-2014
Historic Long-Term Investments for Avadel Pharmaceuticals (AVDL) over the last 5 years, with Dec 2014 value amounting to $125,000.
- Avadel Pharmaceuticals' Long-Term Investments fell 18.83% to $125,000 in Q4 2014 from the same period last year, while for Dec 2014 it was $125,000, marking a year-over-year decrease of 18.83%. This contributed to the annual value of $125,000 for FY2014, which is 18.83% down from last year.
- As of FY2014, Avadel Pharmaceuticals' Long-Term Investments stood at $125,000, which was down 18.83% from $154,000 recorded in FY2013.
- Avadel Pharmaceuticals' Long-Term Investments' 5-year high stood at $186,000 during FY2010, with a 5-year trough of $125,000 in FY2014.
- Over the past 3 years, Avadel Pharmaceuticals' median Long-Term Investments value was $154,000 (recorded in 2013), while the average stood at $154,000.
- In the last 5 years, Avadel Pharmaceuticals' Long-Term Investments grew by 11.59% in 2012 and then dropped by 18.83% in 2014.
- Over the past 5 years, Avadel Pharmaceuticals' Long-Term Investments (Yearly) stood at $186,000 in 2010, then fell by 11.83% to $164,000 in 2011, then grew by 11.59% to $183,000 in 2012, then decreased by 15.85% to $154,000 in 2013, then fell by 18.83% to $125,000 in 2014.